Evidence map›Paper›PMID 22193236›Full record

ReviewClinical journal of the American Society of Nephrology : CJASN2012

Vitamin D therapy in chronic kidney disease and end stage renal disease.

Michal L Melamed, Ravi I Thadhani

Abstract readReview
In one paragraph

Review in Clinical journal of the American Society of Nephrology : CJASN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michal L MelamedDepartment of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. michalmelamed@yahoo.com
Ravi I Thadhani

Funding

Retained Organic Solutes and Clinical Outcomes in HemodialysisR01DK080123 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI POWE, NEIL R. · 2008 to 2012
$3.2M
Ergocalciferol in ESRD Efficacy Safety and BiologyR01DK084974 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI THADHANI, RAVI · 2009 to 2010
$885k
Racial Disparities in Chronic Kidney Disease and Vitamin D: Are they related?K23DK078774 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI MELAMED, MICHAL L · 2007 to 2011
$769k
Alkali Therapy in Chronic Kidney DiseaseR01DK087783 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI HOSTETTER, THOMAS HEARD · 2010 to 2012
$750k
Translational Studies Examining Soluble EPO Receptor and EPO Resistance in DialysR21HL102882 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI THADHANI, RAVI · 2011 to 2012
$502k
NHLBI NIH HHS R21 HL102882NHLBI NIH HHS R21HL102882NIDDK NIH HHS K23 DK078774NIDDK NIH HHS R01 DK080123NIDDK NIH HHS R01 DK084974NIDDK NIH HHS R01DK084974NIDDK NIH HHS R01 DK087783NIDDK NIH HHS R01DK087783
6 · The paper itself

Abstract

Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergocalciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.

Indexed as

Dietary SupplementsChronic DiseaseEvidence-Based MedicineHumansKidney DiseasesKidney Failure, ChronicTreatment OutcomeVitamin DVitamin D DeficiencyVitamin D

Identifiers

PMID22193236
PMCPMC3280034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.